- Home
- QCLS vs EVGN Comparison
QCLS vs EVGN Comparison
Compare QCLS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QCLS
- EVGN
- Stock Information
- Founded
- QCLS 2014
- EVGN 1999
- Country
- QCLS United States
- EVGN Israel
- Employees
- QCLS N/A
- EVGN N/A
- Industry
- QCLS Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EVGN Agricultural Chemicals
- Sector
- QCLS Health Care
- EVGN Industrials
- Exchange
- QCLS Nasdaq
- EVGN Nasdaq
- Market Cap
- QCLS 12.5M
- EVGN 10.9M
- IPO Year
- QCLS N/A
- EVGN N/A
- Fundamental
- Price
- QCLS $3.80
- EVGN $1.11
- Analyst Decision
- QCLS
- EVGN Strong Buy
- Analyst Count
- QCLS 0
- EVGN 1
- Target Price
- QCLS N/A
- EVGN $3.50
- AVG Volume (30 Days)
- QCLS 820.0K
- EVGN 49.2K
- Earning Date
- QCLS 11-19-2025
- EVGN 11-20-2025
- Dividend Yield
- QCLS N/A
- EVGN N/A
- EPS Growth
- QCLS N/A
- EVGN N/A
- EPS
- QCLS N/A
- EVGN N/A
- Revenue
- QCLS N/A
- EVGN $8,016,000.00
- Revenue This Year
- QCLS N/A
- EVGN N/A
- Revenue Next Year
- QCLS N/A
- EVGN $12.35
- P/E Ratio
- QCLS N/A
- EVGN N/A
- Revenue Growth
- QCLS N/A
- EVGN 7.19
- 52 Week Low
- QCLS $2.50
- EVGN $0.95
- 52 Week High
- QCLS $164.00
- EVGN $2.42
- Technical
- Relative Strength Index (RSI)
- QCLS N/A
- EVGN 49.51
- Support Level
- QCLS N/A
- EVGN $1.08
- Resistance Level
- QCLS N/A
- EVGN $1.21
- Average True Range (ATR)
- QCLS 0.00
- EVGN 0.07
- MACD
- QCLS 0.00
- EVGN -0.01
- Stochastic Oscillator
- QCLS 0.00
- EVGN 60.00
About QCLS Q/C Technologies Inc. Common Stock
Q/C Technologies Inc is engaged in building blockchain infrastructure that is faster and more energy-efficient. The company uses laser-based processors inspired by quantum technology that can solve complex problems at the speed of light. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.